Related Experiment Video
Updated: Jun 25, 2025

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.2K
RNA tailing machinery drives amyloidogenic phase transition
Michael Bokros1,2, Nathan C Balukoff1,2, Alex Grunfeld1,2
1Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL 33136.
Summary
The RNA tailing machinery, including TENT4b, modifies RNA to control cellular amyloidogenesis. This process involves starRNA synthesis and degradation by the RNA Exosome, revealing a new enzymatic axis regulating amyloid formation.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- The RNA tailing machinery adds nucleotides to RNA 3'-ends, influencing protein synthesis and stability.
- Intracellular amyloidogenesis, the formation of amyloid bodies, is a critical cellular process.
- The role of RNA modification in amyloidogenesis is not fully understood.
Purpose of the Study:
- To investigate the role of RNA tailing machinery in intracellular amyloidogenesis.
- To identify key enzymes and RNA molecules involved in nucleolar amyloid body formation.
- To elucidate the regulatory mechanisms controlling cellular amyloidogenesis.
Main Methods:
- RNA interference screening to identify essential genes.
- Full-length and mRNA sequencing to discover novel RNA species.
- In vitro and cellular assays to study amyloidogenesis and RNA interactions.
Main Results:
- Terminal Nucleotidyl-transferase 4b (TENT4b) is essential for nucleolar amyloidogenesis.
- TENT4b synthesizes starRNA, long untemplated RNAs that stimulate amyloidogenesis.
- Ribosomal intergenic spacer noncoding RNA (rIGSRNA) recruits TENT4b to nucleoli.
- The RNA Exosome degrades starRNA and suppresses amyloidogenesis.
Conclusions:
- The RNA tailing machinery, specifically TENT4b, acts as an enzymatic modifier of intracellular amyloidogenesis.
- StarRNA molecules synthesized by TENT4b promote amyloid body formation.
- The RNA tailing and RNA Exosome axis tightly controls amyloidogenic phase transitions.
More Related Videos
Related Concept Videos
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K

